Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction
dc.contributor.author | García Etxebarria, Koldo | |
dc.contributor.author | Merino Ochoa, Olga | |
dc.contributor.author | Gaite Reguero, Adrián | |
dc.contributor.author | Rodrigues, Pedro M. | |
dc.contributor.author | Herrarte, Amaia | |
dc.contributor.author | Etxart, Ane | |
dc.contributor.author | Ellinghaus, David | |
dc.contributor.author | Alonso Galán, Horacio | |
dc.contributor.author | Franke, Andre | |
dc.contributor.author | Martínez Marigorta, Urko | |
dc.contributor.author | Bujanda Fernández de Pierola, Luis | |
dc.contributor.author | D’Amato, Mauro | |
dc.date.accessioned | 2022-05-17T09:00:56Z | |
dc.date.available | 2022-05-17T09:00:56Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Scientific Reports 12 : (2022) // Article ID 3386 | es_ES |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | http://hdl.handle.net/10810/56567 | |
dc.description.abstract | [EN] Inflammatory bowel disease (IBD) is characterised by chronic inflammation of the gastrointestinal tract. Although its aetiology remains unknown, environmental and genetic factors are involved in its development. Regarding genetics, more than 200 loci have been associated with IBD but the transferability of those signals to the Basque population living in Northern Spain, a population with distinctive genetic background, remains unknown. We have analysed 5,411,568 SNPs in 498 IBD cases and 935 controls from the Basque population. We found 33 suggestive loci (p < 5 x 10(-6)) in IBD and its subtypes, namely Crohn's Disease (CD) and Ulcerative Colitis (UC), detecting a genome-wide significant locus located in HLA region in patients with UC. Those loci contain previously associated genes with IBD (IL23R, JAK2 or HLA genes) and new genes that could be involved in its development (AGT, BZW2 or FSTL1). The overall genetic correlation between European populations and Basque population was high in IBD and CD, while in UC was lower. Finally, the use of genetic risk scores based on previous GWAS findings reached area under the curves > 0.68. In conclusion, we report on the genetic architecture of IBD in the Basque population, and explore the performance of European-descent genetic risk scores in this population. | es_ES |
dc.description.sponsorship | Samples and data used in the present work were provided by the Basque Biobank (http://www.biobancovasco.org).We want to thank Miguel Angel Vesga from the Basque Centre of Transfusion and Human Tissues for providing the access to control samples. This work was founded to MD by Gipuzkoako Foru Aldundia/Diputacion Foral de Gipuzkoa. The project that gave rise to these results recei | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Nature Research | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | genoma wide association | es_ES |
dc.subject | Crohns desease | es_ES |
dc.subject | database | es_ES |
dc.title | Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://www.nature.com/articles/s41598-022-07401-2 | es_ES |
dc.identifier.doi | 10.1038/s41598-022-07401-2 | |
dc.departamentoes | Medicina | es_ES |
dc.departamentoeu | Medikuntza | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.